{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:47:32Z","timestamp":1784116052463,"version":"3.55.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"1110","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and aim<\/jats:title><jats:p>In 2017, National Health Service Improvement set a 10% reduction target for Escherichia coli bacteraemia by 2018, followed by a 50% reduction in healthcare-associated Gram-negative bacteraemias by 2022. We analysed consecutive cases of E. coli bacteraemia and devised a strategy to achieve these targets.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From December 2012 to November 2013, demographic, clinical and microbiological data were prospectively collected on all patients with bacteraemia at the Royal London Hospital in East London, UK.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 594 significant bacteraemic episodes and 207 (34.8%) were E. coli. Twenty-four (11.6%) of the E. coli isolates were extended spectrum beta-lactamase producers, 22 (10.6%) gentamicin resistant and 2 (1.0%) amikacin resistant. The three most common sites of infection were pyelonephritis 105 (56.7%), catheter-associated urinary tract infection 22 (10.6%), and other medical devices and procedures that cause bacteraemia 32 (15.5%). In the pyelonephritis group, trimethoprim resistance in urinary isolates was 16\/47 (34.0%) compared with 3\/47 (6.4%) for nitrofurantoin. Twelve months postbacteraemia, recurrent bacteraemia rates were 10\/105 (9.5%). There were 44 medical device-associated E. coli bacteraemias, and 22 (50%) were urinary catheter associated. There were 10 patients with E. coli bacteraemia caused by procedures, seven genitourinary or biliary tract instrumentation and three postgastrointestinal surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>E. coli bacteraemias related to urosepsis could have been prevented by better empirical treatment and targeted prophylaxis. Urinary catheter quality improvement programmes should contribute to a further reduction. For patients undergoing high-risk urinary or biliary tract procedures or device manipulation, we advocate single-dose amikacin prophylaxis.<\/jats:p><\/jats:sec>","DOI":"10.1136\/postgradmedj-2017-135454","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T17:16:23Z","timestamp":1519146983000},"page":"212-215","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Strategy to reduce<i>E. coli<\/i>bacteraemia based on cohort data from a London teaching hospital"],"prefix":"10.1093","volume":"94","author":[{"suffix":"Dr","given":"Desmond","family":"Hsu","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Royal London Hospital, Barts Health NHS Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Melzer","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Royal London Hospital, Barts Health NHS Trust , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"2023041307353558900_","article-title":"English surveillance programme for antimicrobial utilisation and resistance (ESPAUR)","author":"Public Health England"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jinf.2007.04.007","article-title":"Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli","volume":"55","author":"Melzer","year":"2007","journal-title":"J Infect"},{"key":"2023041307353558900_","volume-title":"Preventing healthcare associated Gram-negative blood stream infections: an improvement resource","author":"Public Health England and NHS Improvement","year":"2017"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/postgradmedj-2012-131393","article-title":"Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections","volume":"89","author":"Melzer","year":"2013","journal-title":"Postgrad Med J"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2023041307353558900_","article-title":"CDC\/NHSN surveillance definitions for specific types of infections","author":"CDC","year":"2018"},{"key":"2023041307353558900_","article-title":"Management and treatment of common infections \u2013 antibiotic guidance for primary care: for consultation and local adaption","author":"PHE Infection guideline 2017"},{"key":"2023041307353558900_","article-title":"Methenamine hippurate for preventing urinary tract infections","volume":"81","author":"Lee","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041307353558900_","first-page":"CD001321","article-title":"Cranberries for preventing urinary tract infections","volume":"10","author":"Jepson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-013-1091-6","article-title":"D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial","volume":"32","author":"Kranj\u010dec","year":"2014","journal-title":"World J Urol"},{"key":"2023041307353558900_","first-page":"CD005131","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women","author":"Perrotta","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmi.2016.08.003","article-title":"Nitrofurantoin\u2019s efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials","volume":"23","author":"Muller","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"e015233","DOI":"10.1136\/bmjopen-2016-015233","article-title":"Long-term antibiotics for prevention of recurrent urinary tract infection in older adults: systematic review and meta-analysis of randomised trials","volume":"7","author":"Ahmed","year":"2017","journal-title":"BMJ Open"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cir188","article-title":"Reduction of inappropriate urinary catheter use at a Veterans Affairs hospital through a multifaceted quality improvement project","volume":"52","author":"Knoll","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1504906","article-title":"A program to prevent catheter-associated urinary tract infection in acute care","volume":"374","author":"Saint","year":"2016","journal-title":"N Engl J Med"},{"key":"2023041307353558900_","first-page":"CD004203","article-title":"Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults","author":"Kidd","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.advms.2017.05.004","article-title":"Genetic basis of enzymatic resistance of E. coli to aminoglycosides","volume":"63","author":"Ojdana","year":"2017","journal-title":"Adv Med Sci"},{"key":"2023041307353558900_","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cmi.2015.10.034","article-title":"Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals","volume":"22","author":"Fitzpatrick","year":"2016","journal-title":"Clin Microbiol Infect"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/94\/1110\/212\/49838614\/postgradmedj-94-212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/94\/1110\/212\/49838614\/postgradmedj-94-212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T05:22:22Z","timestamp":1693545742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/94\/1110\/212\/6984602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":18,"journal-issue":{"issue":"1110","published-online":{"date-parts":[[2018,2,20]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2017-135454","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,2,20]]}}}